Novartis AG ADR buy The Goldman Sachs Group, Inc.
Start price
30.05.24
/
50%
€92.80
Target price
30.05.25
€110.78
Performance (%)
9.91%
End price
31.05.25
€102.00
Summary
This prediction ended on 31.05.25 with a price of €102.00. With a performance of 9.91%, the BUY prediction by The_Goldman_Sachs_Gr for Novartis AG ADR closed with a slight gain. The_Goldman_Sachs_Gr has a follow-up prediction for Novartis AG ADR, but this time predicts that Novartis AG ADR is a Sell. Dividends of €3.87 are taken into consideration when calculating the performance. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novartis AG ADR | 3.670% | 3.670% | 13.911% |
| iShares Core DAX® | 1.274% | -0.174% | 23.948% |
| iShares Nasdaq 100 | -0.551% | 5.635% | 11.588% |
| iShares Nikkei 225® | -1.032% | 9.513% | 18.120% |
| iShares S&P 500 | 0.229% | 4.847% | 5.994% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Novartis AG ADR diskutieren
Novartis AG (NYSE: NVS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $120.00 price target on the stock.
Ratings data for NVS provided by MarketBeat
In the thread Trading Novartis AG ADR
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten